← Eichor
Study identifier: NCT07290387 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tele-Savvy for Latino Caregivers

Condition: Alzheimer Disease · Dementia · Caregiver Stress  ·  Sponsor: University of Rochester

PhaseNA
Planned participants64
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Latino caregivers of individuals with Alzheimer's disease and related dementias experience high levels of stress burden and depressive symptoms and are underrepresented in caregiver intervention research. Tele Savvy is an evidence based caregiver education program that focuses on developing caregiver mastery skills. This study aims to culturally adapt the Tele Savvy intervention for Latino caregivers and evaluate its preliminary efficacy in a Stage 1b single arm clinical trial. The intervention is delivered remotely and includes weekly group sessions and asynchronous instructional videos. Primary outcomes focus on caregiver mastery with secondary outcomes including stress burden depressive symptoms and self efficacy.

This description comes directly from the study's public registry record.

Talk to the study team

Maria Quiñones, PhD  ·  (585) 276-3903  ·  Maria_Quinones@URMC.Rochester.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Rochester School of NursingRochester, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07290387